Skip to main content

Safety Aspects of β-Blockade in Acute Myocardial Infarction: Experiences from the Gothenburg Metoprolol Trial

  • Conference paper
  • 40 Accesses

Abstract

Several controlled studies with long-term administration of β-blockers in postinfarction patients have demonstrated a reduction of cardiac events and mortality.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Waagstein, F. (1984). Safety Aspects of β-Blockade in Acute Myocardial Infarction: Experiences from the Gothenburg Metoprolol Trial. In: Vincent, J.L. (eds) Intensive Care and Emergency Medicine. Anaesthesiologie und Intensivmedizin / Anaesthesiology and Intensive Care Medicine, vol 167. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69720-3_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-69720-3_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-13412-1

  • Online ISBN: 978-3-642-69720-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics